10,733 Shares in Cognex Corporation $CGNX Acquired by Sequoia Financial Advisors LLC

Sequoia Financial Advisors LLC bought a new stake in Cognex Corporation (NASDAQ:CGNX) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 10,733 shares of the scientific and technical instruments company’s stock, valued at approximately $340,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Geneos Wealth Management Inc. raised its holdings in shares of Cognex by 402.2% in the 1st quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock valued at $27,000 after buying an additional 736 shares during the period. Farther Finance Advisors LLC grew its position in Cognex by 439.4% in the 1st quarter. Farther Finance Advisors LLC now owns 971 shares of the scientific and technical instruments company’s stock valued at $29,000 after acquiring an additional 791 shares in the last quarter. GAMMA Investing LLC increased its stake in Cognex by 155.3% during the first quarter. GAMMA Investing LLC now owns 1,062 shares of the scientific and technical instruments company’s stock worth $32,000 after purchasing an additional 646 shares during the period. MassMutual Private Wealth & Trust FSB lifted its position in shares of Cognex by 231.9% during the second quarter. MassMutual Private Wealth & Trust FSB now owns 1,082 shares of the scientific and technical instruments company’s stock worth $34,000 after purchasing an additional 756 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd boosted its stake in shares of Cognex by 82.6% in the first quarter. Caitong International Asset Management Co. Ltd now owns 1,749 shares of the scientific and technical instruments company’s stock valued at $52,000 after purchasing an additional 791 shares during the period. 88.12% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the stock. JPMorgan Chase & Co. started coverage on shares of Cognex in a report on Monday, September 15th. They set a “neutral” rating and a $45.00 target price on the stock. DA Davidson increased their price objective on Cognex from $32.00 to $35.00 and gave the company a “neutral” rating in a research note on Monday, August 4th. Melius upgraded Cognex from a “hold” rating to a “buy” rating and set a $60.00 target price for the company in a report on Thursday, July 10th. UBS Group upped their price target on Cognex from $53.00 to $58.00 and gave the stock a “buy” rating in a report on Friday, August 1st. Finally, Barclays set a $55.00 price objective on Cognex and gave the company an “overweight” rating in a research note on Tuesday, October 7th. Two investment analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Cognex has a consensus rating of “Moderate Buy” and a consensus target price of $44.93.

Insider Activity

In other Cognex news, EVP Sheila Marie Dipalma sold 2,002 shares of the firm’s stock in a transaction dated Friday, September 5th. The stock was sold at an average price of $45.00, for a total transaction of $90,090.00. Following the transaction, the executive vice president owned 8,582 shares of the company’s stock, valued at approximately $386,190. This trade represents a 18.92% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 1.60% of the company’s stock.

Cognex Stock Performance

Shares of NASDAQ CGNX opened at $48.27 on Wednesday. The stock’s 50-day simple moving average is $44.88 and its 200-day simple moving average is $35.76. The firm has a market capitalization of $8.10 billion, a PE ratio of 67.99 and a beta of 1.50. Cognex Corporation has a fifty-two week low of $22.67 and a fifty-two week high of $49.76.

Cognex (NASDAQ:CGNX) last announced its quarterly earnings results on Wednesday, July 30th. The scientific and technical instruments company reported $0.25 EPS for the quarter, beating the consensus estimate of $0.23 by $0.02. The company had revenue of $249.09 million for the quarter, compared to analyst estimates of $246.70 million. Cognex had a net margin of 13.13% and a return on equity of 6.65%. The firm’s revenue was up 4.2% on a year-over-year basis. During the same period in the prior year, the firm posted $0.23 earnings per share. Cognex has set its Q3 2025 guidance at 0.240-0.290 EPS. On average, sell-side analysts forecast that Cognex Corporation will post 0.61 earnings per share for the current fiscal year.

Cognex Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, August 28th. Investors of record on Thursday, August 14th were given a $0.08 dividend. The ex-dividend date of this dividend was Thursday, August 14th. This represents a $0.32 dividend on an annualized basis and a yield of 0.7%. Cognex’s payout ratio is 45.07%.

Cognex Company Profile

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.